About Nectome
Nectome is a company based in San Francisco (United States) founded in 2015 by Robert McIntyre and Michael McCanna. Nectome operates in a competitive market with competitors including Brooks Automation, Hemanext, Bridge to Life, Cellbox Solutions and Atelerix, among others.
- Headquarter San Francisco, United States
- Founders Robert McIntyre, Michael McCanna
- SectorsHealthcare
- Email••••••••
- Website nectome.com
- Investors
Funding Insights of Nectome
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Nectome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2018 | – | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Nectome
Nectome has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated via funding and educational programs. | – | ycombinator.com | Mountain View, United States |
Investor details for Nectome
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nectome
2 people are tracked at Nectome (2 in leadership).
| Name | Role | Group |
|---|---|---|
Robert McIntyre | Co-Founder & CEO | Leadership |
Michael McCanna | Co-Founder | Leadership |
Complete people profiles for Nectome
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nectome
2 dated milestones of Nectome across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Nectome is founded.
- Funding First funding round.
Competitors of Nectome
Nectome operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brooks Automation, Hemanext, Bridge to Life, Cellbox Solutions and Atelerix, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| brooks.com | 1978 | Chelmsford, United States | – | 1,928 | Vacuum robots for semiconductor wafer handling are developed. | |
| hemanext.com | 2004 | Lexington, United States | $127.57M | 53 | Technologies for blood and product storage are developed. | |
| bridgetolife.com | 2012 | Columbia, United States | $57M | – | Cold storage solutions for organ transplant preservation are provided. | |
| cellbox-solutions.com | 2016 | Lubeck, Germany | $6.99M | – | Portable devices for cell storage and transport are provided. | |
| atelerix.co.uk | 2017 | Newcastle Upon Tyne, United Kingdom | $2.43M | 9 | Technology for cell storage and transportation is developed. | |
| genepoint.cn | 2015 | Shanghai, China | $48.3M | – | Platform for cryostorage and long-term biological preservation is provided. | |
| pantheracryo.com | 2018 | Edmonton, Canada | $6M | – | Cryopreservation platform for cells, tissues, and organs is provided. | |
| coldchaintech.com | 2001 | Franklin, United States | – | – | Thermal packaging solutions and cold chain monitoring services are provided. | |
| biocision.com | 2007 | Larkspur, United States | $11.1M | 48 | Provider of handling, storage and transport solutions for temperature-sensitive biomedical samples and drugs | |
| transplantbiomed.com | 2014 | Barcelona, Spain | $4.24M | – | Devices for organ and tissue transport are developed. |
Detailed competitors of Nectome
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nectome
The website of Nectome (nectome.com) receives about 6.6K visits a month.
- Monthly visits6.6K
▲ 29.3% vs previous month
Latest news on Nectome
Complete news archive for Nectome
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Nectome
10 companies that operate in the same segment as Nectome (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nectome
Nectome was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Nectome is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Robert McIntyre is the current CEO of Nectome. They have also founded this company.
The company was founded in 2015 in San Francisco, United States, focusing on biotechnology for brain preservation. Techniques employed include fixation with glutaraldehyde to stabilize synapses and halt decay, altering the brains watery state to a rubber-like consistency. This is followed by vitrification at -122C for extended storage. Such methods, established over decades for biological specimens like organs and animals, support long-term preservation services in the sector.
Nectome's top competitors include Brooks Automation, Hemanext and Bridge to Life.
Nectome has 1 investor. Key investors include Y Combinator.